Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruxolitinib vs BAT in Polycythemia Vera (RESPONSE)
NCT01243944Phase 3Completed
- Sponsor
- Incyte
- Start
- Oct 2010
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of ruxolitinib in polycythemia vera (PV), sponsored by Incyte. Started Oct 2010; status: completed.
02
Drugs
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on NCT01243944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01243944.